Elutia (Nasdaq:ELUT) announced today that it agreed to sell its bioenvelope technologies to Boston Scientific for $88 million. Gaithersburg, Maryland-based Elutia agreed to sell its EluPro and CanGaroo drug-eluting bioenvelopes in the cash deal. It designed these technologies to protect patients receiving implantable medical devices. Elutia says the deal underscores the value of its proprietary […]
Mergers & Acquisitions
MannKind enters cardiometabolic, lung disease drug delivery space with scPharmaceuticals acquisition
MannKind (Nasdaq:MNKD) announced today that it entered into a definitive agreement under which it acquires scPharmaceuticals. The proposed acquisition could deliver MannKind’s strategic expansion into cardiorenal medicine. Danbury, Connecticut-based MannKind already offers inhaled insulin therapy. scPharmaceuticals, meanwhile, markets Furoscix, an FDA-approved on-body unfuser delivering furosemide. Furosemide currently serves as the standard for treating fluid overload […]
Ypsomed completes sale of diabetes care business to TecMed
Ypsomed announced today that it successfully completed the sale of its diabetes care business to TecMed AG. Burgdorf, Switzerland–based Ypsomed in April announced its plans to sell the business to help focus on strengthening its position in the subcutaneous self-injection market. TecMed — also based in Burgdorf — can now add Ypsomed’s insulin delivery technology […]
Ypsomed to sell diabetes business, insulin delivery tech to TecMed for $517.7M
Ypsomed announced today that it agreed to sell its diabetes care business to TecMed for up to approximately $517.7 million (CHF 420 million). Burgdorf, Switzerland–based Ypsomed says the sale helps it focus on strengthening its position in the subcutaneous self-injection market. TecMed — also based in Burgdorf — can now add Ypsomed’s insulin delivery technology […]
Vivani to spin out neurostim business, focus on GLP-1 implant
Vivani Medical (Nasdaq:VANI) announced today that it plans to spin off Cortigent, a division that develops brain implants. The company wants to create two focused companies dedicated to driving current and future value in their respective therapeutic areas. Vivani aims to continue advancing its miniature GLP-1 therapeutic implants. The spin-off would enable Cortigent to continue […]
Henry Schein completes acquisition of CGM supplier Acentus
Henry Schein (Nasdaq: HSIC) announced today that it completed the acquisition of substantially all the assets of Acentus. Tampa, Florida-based Acentus, a national medical supplier, specializes in the delivery of continuous glucose monitors (CGMs). The company reports annual revenue of approximately $35 million. Melville, New York-based Henry Schein announced its agreement to acquire the company […]
Phillips Medisize enhances inhaled drug delivery portfolio with Vectura acquisition
Phillips Medisize parent company Molex announced today that it completed its acquisition of Vectura from a subsidiary of cigarette maker Philip Morris. The company says adding Vectura enables it to offer a wider range of formulation, device design, combination product development and manufacturing services. It acquires Vectura’s proprietary technology and combination product development expertise in dry […]
Boston Scientific to acquire hepatic artery infusion pump maker Intera Oncology
Boston Scientific (NYSE:BSX) announced today that it agreed to acquire infusion pump maker Intera Oncology for an undisclosed amount. Intera Oncology develops the Intera 3000 hepatic artery infusion pump and floxuridine, a chemotherapy drug. Both hold FDA approval. The pump administers hepatic artery infusion (HAI) therapy to treat tumors in the liver primarily caused by […]
Phillips Medisize to buy inhaled drug delivery device maker Vectura from Philip Morris
Phillips Medisize parent company Molex announced that it agreed to acquire Vectura from a subsidiary of cigarette maker Philip Morris. Vectura designs and develops devices and formulations for inhaled drug delivery. Philip Morris paid $1.2 billion for the UK-based company in 2021 as part of its “Beyond Nicotine” effort to phase out cigarettes and develop […]
Ypsomed closes pen needle, BGM business sale to focus on insulin pump
Ypsomed announced today that it completed the sale of its pen needle and blood glucose monitoring (BGM) businesses to Medical Technology and Devices (MTD). The Burgdorf, Switzerland-based company first announced an agreement to sell off those businesses to MTD in March. Ypsomed plans to support a reliable transition to ensure pen needle supply amid the […]
